# Bioreliance Corporation – FDA Inspection, Jan 29, 2026

Source: https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/e199758b-3727-437f-82a7-ea444bde9780
Source feed: FDA_Inspections

> FDA inspection 1295306 of Bioreliance Corporation, January 29, 2026. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 58. Form 483 issued. 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1295306
- Company Name: Bioreliance Corporation
- Inspection Date: 2026-01-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Baltimore District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1254934 - 2024-11-22](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/7941bc6b-db19-4266-b05d-af8a19fbde51)
- [FDA Inspection 1215040 - 2023-08-04](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/89149f6b-0201-4f3c-9500-60de669dfba4)
- [FDA Inspection 1099981 - 2019-08-08](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/7e151514-be3f-4b8f-ba64-e4ad411f7cc0)
- [FDA Inspection 1059115 - 2018-07-13](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/ba69306a-6c03-404f-b4e3-7b18e0e140f0)
- FDA Inspection 983525 - 2016-01-11

## Related Officers

- [Investigator](https://www.keypedia.com/people/david-l-chon/227b9c21-14c4-442b-bdc3-ad167567fd92)

Company: https://www.keypedia.com/companies/bioreliance-corporation/08d3dc20-6c7e-4f04-bb98-bbc868e70000

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa
